clofibride has been researched along with rizatriptan in 1 studies
| Studies (clofibride) | Trials (clofibride) | Recent Studies (post-2010) (clofibride) | Studies (rizatriptan) | Trials (rizatriptan) | Recent Studies (post-2010) (rizatriptan) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 349 | 106 | 75 |
| Protein | Taxonomy | clofibride (IC50) | rizatriptan (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.3572 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 6.3096 | |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.0452 | |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | 0.041 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 7.9433 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 7.9433 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 3.9811 | |
| 5-hydroxytryptamine receptor 1D | Sus scrofa (pig) | 0.0501 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 3.9811 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
1 other study(ies) available for clofibride and rizatriptan
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |